Finance

Lists
Why is ACHV up 5,20%?
Dive Deeper
ACHV:NASDAQ
Achieve Life Sciences Inc
8,09 $
+5,20%
(+0,40) 1D
8,00 $
-1,11% (-0,090)
After hours
Closed: 30 қыр., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACHV...
Open
8,08 $
High
8,28 $
Low
7,87 $
Mkt. cap
832,48 млн
Avg. vol.
1,58 млн
Volume
2,38 млн
52-wk high
8,61 $
52-wk low
2,62 $
EPS
-1,55 $
Beta
2,25
Shares outstanding
102,90 млн
No. of employees
28
Open
8,08 $
High
8,28 $
Low
7,87 $
Mkt. cap
832,48 млн
Avg. vol.
1,58 млн
Volume
2,38 млн
52-wk high
8,61 $
52-wk low
2,62 $
EPS
-1,55 $
Beta
2,25
Shares outstanding
102,90 млн
No. of employees
28
News stories
From web sources and news partners
About Achieve Life Sciences Inc
CEO-
Employees28
Founded1991
HeadquartersСиэтл, Вашингтон, Америка Құрама Штаттары
Sector-
Websiteir.achievelifesciences.com
Analyst ratings
Based on 6 analysts giving stock ratings to ACHV in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ACHV in the last 3 months.
Highest
Current 8,09 $
18,00 $ (+122,50%)
Average
13,83 $ (+70,95%)
Lowest
10,00 $ (+23,61%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Condulis
Stifel Nicolaus
Buy
Initiated
18,00 $
+122,5%
09/30/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
17,00 $
+110,1%
09/03/2026
Jason McCarthy
Maxim Group
Buy
Maintained
10,00 $
+23,6%
08/12/2026
Maxwell Skor
Morgan Stanley
Buy
Initiated
13,00 $
+60,7%
08/13/2026
Gary Nachman
Canaccord Genuity
Buy
Reiterated
13,00 $
+60,7%
08/12/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
12,00 $
+48,3%
08/11/2026
Ryan Deschner
Raymond James
Buy
Initiated
20,00 $
+147,2%
06/26/2026
Mark Smith
Lake Street
Buy
Maintained
11,00 $
+36%
05/13/2026
Justin Walsh
JonesTrading
Buy
Reiterated
20,00 $
+147,2%
05/12/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
13,00 $
+60,7%
04/20/2026
Thomas Flaten
Lake Street
Buy
Maintained
11,00 $
+36%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,32 млн
3,87 млн
3,29 млн
3,81 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,37 млн
10,86 млн
7,17 млн
14,58 млн
Operating expense
14,69 млн
14,73 млн
10,46 млн
18,39 млн
Total operating expenses
14,69 млн
14,73 млн
10,46 млн
18,39 млн
Operating income
-14,69 млн
-14,73 млн
-10,46 млн
-18,39 млн
Other non operating income
-5,00 мың
7,00 мың
-13,00 мың
-57,48 млн
EBT including unusual items
-14,44 млн
-14,66 млн
-10,17 млн
-74,77 млн
EBT excluding unusual items
-14,34 млн
-14,55 млн
-10,45 млн
-74,67 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,44 млн
-14,66 млн
-10,17 млн
-74,77 млн
Net profit margin
-
-
-
-
Earnings per share
-0,28
-0,28
-0,19
-0,80
Interest and investment income
554,00 м.
427,00 м.
297,00 м.
1,48 млн
Interest expense
-192,00 м.
-251,00 м.
-274,00 м.
-277,00 м.
Net interest expenses
362,00 м.
176,00 м.
23,00 мың
1,20 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,64 млн
-14,67 млн
-10,41 млн
-18,34 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары